That sure is a lot of words that say absolutely nothing! I didn’t mention Adam F so why are you?
The contortionist view is mildly amusing as many have backed themselves into a corner of stating the stock is “totally de-risked” and popping off about OS percentages, then simultaneously saying the reason for the long delay and silence is an embargo. One can’t have it both ways.
Which is it? The company did or diD NOT release info? According to you, they didn’t not. I agree from a technical standpoint.
Now, here is where the comedy starts.
Are most bullish investors relying on the ASCO data? Yes!
Were percentages and numbers from the trial released at that presentation? Yes!
Did the presenter make the shit up or did they have access to the trial data? If the latter, then many are running on hopium. If the former, then the trial data was partially released.
You can write paragraphs-long responses all you want. It comes down to this simple question and answer:
Was the data presented on May 10 accurate and sourced by NWBO? Yes or No? Just answer the question with those two choices.
YES or NO!
Market Data 
Markets 
AI
